Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: Lesion Sterilization and Tissue Repair Antibiotic Paste Versus Zinc Oxide and Eugenol Pulpectomy for Treatment of Primary Molars With Pulp Necrosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing Lesion Sterilization and Tissue Repair Antibiotic Paste with Zinc Oxide and Eugenol pulpectomy for treating pulp necrosis i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lesion Sterilization and Tissue Repair Antibiotic Paste (LAST-AP)
  • Zinc Oxide and Eugenol Pulpectomy Material (zinc oxide eugenol)

Snippet

Sponsor: University of Faisalabad | Conditions: Pulp Necrosis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING